flufenamic acid has been researched along with 4-aminopyridine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Chen, S; Inoue, R; Ito, Y | 1 |
Farrugia, G; Rae, JL; Sarr, MG; Szurszewski, JH | 1 |
Jung, MW; Kang, GH; Kang, YS; Kim, JA; Lee, SH; Lee, YS | 1 |
Fernández, M; Lao-Peregrín, C; Martín, ED | 1 |
6 other study(ies) available for flufenamic acid and 4-aminopyridine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Pharmacological characterization of muscarinic receptor-activated cation channels in guinea-pig ileum.
Topics: 4-Aminopyridine; Acetylcholine; Animals; Caffeine; Calcium Channels; Diphenylamine; Egtazic Acid; Electrophysiology; Female; Flufenamic Acid; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Ileum; In Vitro Techniques; Ion Channels; Male; Membrane Potentials; Muscle, Smooth; Nystatin; Procaine; Quinine; Receptors, Muscarinic; Tetraethylammonium Compounds | 1993 |
Potassium current in circular smooth muscle of human jejunum activated by fenamates.
Topics: 4-Aminopyridine; Cadmium; Flufenamic Acid; Humans; In Vitro Techniques; Ion Channel Gating; Jejunum; Kinetics; Mefenamic Acid; Membrane Potentials; Muscle, Smooth; Potassium Channels; Potassium Chloride; Probability; Quinidine; Rubidium; Tetraethylammonium; Tetraethylammonium Compounds | 1993 |
Ca2+ influx mediates apoptosis induced by 4-aminopyridine, a K+ channel blocker, in HepG2 human hepatoblastoma cells.
Topics: 4-Aminopyridine; Apoptosis; Calcium; Calcium Channel Blockers; Cell Survival; Chelating Agents; DNA Fragmentation; Egtazic Acid; Flufenamic Acid; Hepatoblastoma; Humans; Liver Neoplasms; Manganese; Membrane Potentials; Nifedipine; Potassium Channel Blockers; Potassium Channels; Tumor Cells, Cultured; Verapamil | 2000 |
Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability.
Topics: 4-Aminopyridine; Action Potentials; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Epilepsy; Excitatory Postsynaptic Potentials; Flufenamic Acid; gamma-Aminobutyric Acid; Hippocampus; Inhibitory Postsynaptic Potentials; Neural Inhibition; Neurons; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2010 |